Hepatic Tumors
Overview of Hepatic Tumors
Types of Tumors:
Cancerous: 1. Primary (originate in liver, uncommon), 2. Metastatic (from other body sites).
Benign: e.g., Hepatic Adenomas (more common in women on oral contraceptives).
Types of Cancerous Hepatic Tumors
Primary Cancerous Tumors:
Hepatocellular Carcinoma (HCC) (rare, primary).
Cholangiocarcinoma (bile duct lining).
Mixed Tumors (epithelial and mesenchymal cells).
Angiosarcoma (blood vessels).
Hepatoblastoma (children, can cause early puberty).
Risk Factors for Cancerous Hepatic Tumors
Key Factors:
Viral Infections (Hepatitis B & C).
Chronic Alcohol Use.
Cirrhosis (alcoholic & non-alcoholic).
Exposure to Toxins, Anabolic Steroids.
Age (over 60), Sex (men double risk), Race (Asians highest risk).
Lifestyle (smoking) & Genetic Factors.
Metastatic Hepatic Tumors
Can originate from cancers in the colon, breast, lung, kidney, pancreas, stomach, etc.
Symptoms and Signs of Cancerous Hepatic Tumors
Early Stages: Often asymptomatic.
Possible Symptoms:
Pain (right upper abdomen, referred to shoulder/back/epigastric area).
Fever (without infection).
Jaundice (with bile duct obstruction).
Indigestion, loss of appetite, weight loss, nausea.
Abdominal/Leg swelling (edema).
Generalized Weakness, Enlarged Liver (Hepatomegaly).
Biopsy Considerations
Post-Biopsy Care: Patient should lie on affected side; monitor vital signs (pulse, BP, RR for bleeding/shock), check insertion site, manage pain.
Staging and Diagnosis
Diagnosis: Abdominal Ultrasound, Blood Counts, Clotting Tests (PT, PTT).
Staging System: AJCC TNM Classification (: Tumor size/spread, : Lymph Node involvement, : Metastasis).
T Stages: T0 (no tumor), T1 (single without vessel invasion), T2 (single with vessel invasion or multiple <5 cm), T3 (multiple >5 cm or major vessel invasion), T4 (invading neighboring organs).
N Stages: N0 (no regional spread), N1 (regional spread).
M Stages: MX (unasessable), M0 (no distant spread), M1 (distant spread).
Treatment Options for Liver Cancer
Surgical Treatment
Limited candidates due to tumor location/recurrence risk.
Options: Lobectomy, Liver Transplantation (stringent criteria), Cryosurgery, Ethanol/Microwave Coagulation.
Non-Surgical Treatment
Chemotherapy: Adriamycin, 5-FU, cisplatin (single or combination).
Chemoembolization (direct to tumor via hepatic artery).
Percutaneous Biliary Drainage (external).
Radiation Therapy: Mostly supportive/palliative, sometimes post-surgery.
Thermal Ablation: For coagulation necrosis.
Cirrhosis increases surgical risk and complicates non-surgical choices.
Post-Operative Monitoring and Management
Immediate Monitoring: Assess for hypoglycemia, hypovolemia, hypothermia, bile leakage, infections.
Management: Blood transfusions, IV therapy, hypothermia treatment.
Patient Education and Follow-Up Care
Key Aspects: Dietary recommendations, drainage system management, chemotherapy/radiation follow-up, psychosocial support, infection monitoring, port management, reassurance, scheduled follow-up appointments.